Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-091410
Filing Date
2025-09-25
Accepted
2025-09-25 09:23:39
Documents
1
Period of Report
2025-09-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0258753-6k_neurosense.htm 6-K 9409
  Complete submission text file 0001213900-25-091410.txt   10474
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41084 | Film No.: 251340589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)